Avista Capital Partners’ Acquisition of Kramer Laboratories, Inc.

Ropes & Gray LLP acted as legal counsel to Avista. Akerman LLP acted as legal counsel to Kramer.

Avista Capital Partners, a leading private equity firm, in partnership with Dana Holdings, a consumer healthcare-focused private investment group, finalized its acquisition of Kramer Laboratories, Inc., a marketer of over-the-counter (OTC) foot care and specialty cough products.

Kramer, based in Coral Gables, Florida, is a recognized leader in OTC foot care products. The Company’s portfolio includes leading foot care brands such as The Original Fungi-Nail® Toe & Foot® and HC Max™, as well as the Safetussin® brand of specialty cough solutions. The Company’s products are sold in over 60,000 stores nationwide, including major drug, food and mass merchandiser outlets.

Founded in 2005, Avista is a leading New York-based private equity firm with over $6 billion invested in more than 30 growth-oriented healthcare businesses.

The Ropes & Gray team was led by private equity partner David Blittner (Picture) and included associates Ted Schmadeke, Hanah Kim and Kyung Paik.

Involved fees earner: David Blittner – Ropes & Gray; Ted Schmadeke – Ropes & Gray; Hanah Kim – Ropes & Gray; Kyung Paik – Ropes & Gray;

Law Firms: Ropes & Gray;

Clients: Avista Capital Partners;


Author: Ambrogio Visconti